German chemicals giant BASF raised its full-year 2026 earnings guidance after a stronger-than-expected third quarter, but analysts are cautioning that the company's real challenge lies in converting those improved profits into cash. The company's updated outlook, announced alongside its Q3 results, lifted the midpoint of its 2026 EBITDA (earnings before interest, taxes, depreciation, and amortization) before special items forecast to €7.6 billion, up from €7.3 billion previously.
BASF reported third-quarter sales of €16.36 billion, a 14.2% increase year-over-year. The company now expects 2026 EBITDA before special items to land between €7.4 billion and €7.8 billion, compared with its earlier range of €6.9 billion to €7.7 billion. The upward revision reflects a stronger quarter, but analysts at Mwb Research attribute much of the improvement to temporary pricing gains in upstream chemicals and early benefits from the company's restructuring efforts. They also warn that end-market demand remains soft and input costs are still volatile.
The cash conversion problem
While the earnings upgrade grabbed headlines, the more pressing issue for investors is BASF's cash generation. The company generated just €523 million of free cash flow in the third quarter, leaving it at negative €1.04 billion for the first nine months of the year. That shortfall is significant because BASF has maintained its full-year 2026 free cash flow target of €1.5 billion to €2.3 billion, even after cutting its expected capital expenditure by about €550 million to a range of €2.8 billion to €2.9 billion.
To hit that target, Mwb Research estimates BASF would need to generate between €2.5 billion and €3.3 billion of free cash flow in the fourth quarter alone. That would require a substantial pickup in operating cash flow, likely through releasing working capital or converting more of its earnings into cash. The company's ability to do so is now the key question for investors.
“Raising an earnings target matters less if leverage and flexibility still depend on a late-year cash surge,” said the Mwb note. Since BASF kept its free cash flow goal unchanged despite lowering capex, the focus shifts to Q4's cash print. That cash must come from day-to-day operations, not just from spending less on projects.
What it means for investors
For everyday investors, this story is a reminder that earnings and cash flow are not the same thing. A company can report higher profits but still struggle to generate the cash needed to pay dividends, reduce debt, or invest in growth. BASF's situation illustrates why analysts and investors often look beyond the headline profit numbers.
If BASF fails to deliver the expected Q4 cash surge, the upgraded EBITDA range may not translate into a lower-risk valuation. Mwb's price target of €55 per share, for example, would face a tougher “guidance credibility” test. The market will be watching closely when BASF reports its fourth-quarter results early next year.
This earnings season has already put 2026 targets under the microscope across Europe, as investors scrutinize whether companies can back up their forecasts with actual performance. BASF's case is a prime example of that dynamic.
For those holding BASF shares or considering an investment, the key metric to watch is not just the EBITDA guidance but the free cash flow figure. A strong Q4 cash performance would bolster confidence in the company's turnaround plan, while a miss could raise questions about the sustainability of its earnings recovery.
BASF's restructuring efforts, which include cost cuts and portfolio adjustments, are designed to improve profitability and cash generation over time. But as the Q3 numbers show, progress can be uneven. The company's ability to convert its improved earnings into cash will be a critical test of whether the turnaround is on track.
In the broader context, BASF's results also offer a window into the health of the global chemicals industry, which is sensitive to economic cycles. Soft end-demand and volatile input costs are challenges that many chemical makers face, and BASF's experience may be indicative of broader industry trends.
For now, the market's attention will be on BASF's fourth-quarter cash flow. If the company can deliver the €2.5-3.3 billion needed to meet its full-year target, it will go a long way toward validating the upgraded earnings outlook. If not, investors may need to reassess the company's financial flexibility and the credibility of its guidance.
